Oxford, United Kingdom

Simon Richards

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Richards. Retrieved from https://idiyas.com/inventor/simon-richards-uv88art4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Richards: Innovator in MALT-1 Modulation

Introduction: Simon Richards is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical research, particularly in the modulation of MALT-1. His work focuses on developing compounds that can treat various diseases and conditions.

Latest Patents: Simon Richards holds 1 patent for his invention related to MALT-1 modulators. The patent discloses compounds, compositions, and methods for treating diseases, syndromes, conditions, and disorders that are influenced by the modulation of MALT-1. These compounds are represented by specific formulas, wherein the variables are defined in the patent documentation.

Career Highlights: Simon is currently employed at Recursion Pharmaceuticals, Inc., where he continues to advance his research in the field. His innovative approach to drug development has positioned him as a key player in the pharmaceutical industry.

Collaborations: Simon Richards has collaborated with notable colleagues, including Peter Ray and David Evans. Their combined expertise enhances the research efforts at Recursion Pharmaceuticals, Inc.

Conclusion: Simon Richards exemplifies the spirit of innovation in the pharmaceutical sector through his work on MALT-1 modulators. His contributions are paving the way for new treatments that could significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…